Issue Date: April 1, 1996
Issued by: Center for Devices and Radiological Health
Topic(s): Radiological Health
Status: Final
This guidance describes FDA’s policies on user facility medical device reporting requirements.
Download the Guidance Document
Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.
